Long-term workplace exposure to formaldehyde may prompt thinking and memory problems later in life, new research suggests. Formaldehyde is a gas used in making wood and chemical products and plastics. “We know that exposure to formaldehyde has been linked to certain cancers, and our results suggest that exposure to low amounts of formaldehyde also may… read on > read on >
All Health and Wellness:
FDA OKs Pfizer Pill as First At-Home COVID Treatment
The U.S. Food and Drug Administration on Wednesday approved the emergency use of Pfizer’s new antiviral pill Paxlovid in people who are at high risk for severe COVID-19. It’s the first approved treatment for COVID-19 meant to be taken at home. “Today’s authorization introduces the first treatment for COVID-19 that is in the form of… read on > read on >
NYC’s Overdose Prevention Centers Already Saving Lives
At least 59 overdoses were prevented in the first three weeks that two overdose prevention centers have been open in New York City, the city’s health department said Tuesday. During that time, there were more than 2,000 visits to the centers that are operated by OnPoint NYC and are the first publicly recognized overdose prevention… read on > read on >
U.S. Army Reports Progress on COVID Vaccine That Fights All Variants
The U.S. Army says it has developed a COVID-19 vaccine it believes could work against any and all coronavirus variants, including Omicron. Results from early human trials of the Spike Ferritin Nanoparticle (SpFN) COVID vaccine are expected by the end of the month, the Army added. Lab studies have already shown that the new vaccine… read on > read on >
Americans’ Stigma Against Depression May Finally Be Fading: Study
Americans may be dropping some of the stigma they once had toward depression, but attitudes toward other mental health conditions still seem stuck in the past, a new study shows. The research, based on interviews with U.S. adults conducted over 22 years, found a mixed bag when it came to mental health stigma. In general,… read on > read on >
Trump Tells Followers He Got a Booster Shot. They Booed.
After former President Donald Trump said he had gotten a booster shot during an event in Texas this week, boos erupted from parts of the crowd. The incident occurred Sunday during a stop of Trump’s tour with former Fox News host Bill O’Reilly and was recorded in a video tweeted by O’Reilly’s “No Spin News.”… read on > read on >
AHA News: 12-Year-Old Is on a Mission to Kick Kawasaki Disease
WEDNESDAY, Dec. 22, 2021 (American Heart Association News) — Aubrey Virgin was a healthy, active 2-year-old when she developed a high fever. Then came a rash that quickly spread over her body. Lymph nodes in her neck swelled. So did her lips, hands and feet. Aubrey cried when her mother, Shannon, touched her. Shannon rushed… read on > read on >
Going Viral: Flu Rebounds as Omicron Variant Surges
Flu is making a comeback in the United States this year, with cases rising around the country even as the Omicron variant is surging, infectious disease experts say. “We already are seeing significant increases in the amount of influenza occurring across the United States, especially with regards to the eastern part of the U.S. and… read on > read on >
Who’s Dying Young in U.S. From Heart Attacks?
Fewer Americans are dying prematurely from heart attack compared with years ago, but progress has stalled out in the past decade, new research shows. For the study, the researchers examined 20 years of data on heart attack deaths among Americans under 65 — deaths that are considered “premature.” The bigger picture looked good: Between 1999… read on > read on >
AHA News: Making a Lifetime of Good Brain Health a Global Priority
WEDNESDAY, Dec. 22, 2021 (American Heart Association News) — Twenty years ago, the Canadian province of Ontario launched an aggressive campaign to tackle stroke from every angle: It hyped prevention and awareness; beefed up its acute care practices and response times; and increased access to post-stroke rehabilitation. It worked. Stroke rates fell 32% within a… read on > read on >